How does bacterial resistance to erythromycin develop, including genetic mutations or efflux pumps and what are the implications for its long-term use?
Lakshya KumarExplorer
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Bacterial resistance to erythromycin often develops through genetic mutations that alter ribosomal binding sites or via efflux pumps that expel the drug. Prolonged use may reduce treatment efficacy.